Evaluation of efficacy of Letrozole on the duration and severity of Ovarian hyperstimulation syndrome

Phase 2

• Conditions: Ovarian hyperstimulation syndrome.; Hyperstimulation of ovaries; N98.1

• Registration Number: IRCT20141008019464N2
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Having Ovarian hyperstimulation syndrome

Exclusion Criteria

Lack of incidence of hyperstimulation syndrome after receiving ovarian stimulant drug due to infertility
Patient dissatisfaction to participate in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration of Ovarian hyperstimulation syndrome. Timepoint: 2-3 weeks after intervention. Method of measurement: laboratory tests.

Secondary Outcome Measures

Name	Time	Method
iver enzymes. Timepoint: 2 weeks after intervention. Method of measurement: laboratory tests.;Hematocrit. Timepoint: 2 weeks after intervention. Method of measurement: laboratory tests.;Ratio of urea to creatinine. Timepoint: 2 weeks after intervention. Method of measurement: laboratory tests.;Evacuation of ascites. Timepoint: 7 & 14 days after intervention. Method of measurement: Number of ascites Evacuations.;Existence of thrombosis. Timepoint: 7 & 14 days after intervention. Method of measurement: Ultrasound.;Ovary size. Timepoint: 2 weeks after intervention. Method of measurement: Ultrasound.;Shortness of breath. Timepoint: 7 & 14 days after intervention. Method of measurement: history.